Telesis Bio, Inc. (TBIO)
OTCMKTS · Delayed Price · Currency is USD
1.500
-0.200 (-11.76%)
Oct 25, 2024, 3:30 PM EDT

Telesis Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Oct '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
31235317--
Market Cap Growth
-86.92%-66.23%-88.81%---
Enterprise Value
59497222--
Last Close Price
1.527.1821.60194.40--
PE Ratio
--0.24-0.73-5.05--
PS Ratio
0.130.431.2928.66--
PB Ratio
0.620.410.763.49--
P/FCF Ratio
-0.27-0.33-0.82-8.21--
P/OCF Ratio
-0.28-0.35-0.92-8.62--
EV/Sales Ratio
2.991.790.2620.13--
EV/EBITDA Ratio
-1.72-1.50-0.16-6.51--
EV/EBIT Ratio
-1.59-1.40-0.15-6.34--
EV/FCF Ratio
-2.57-1.34-0.16-5.77--
Debt / Equity Ratio
3.571.160.460.190.620.15
Debt / FCF Ratio
-1.56-0.94-0.50-0.45-0.53-0.61
Asset Turnover
0.230.360.280.150.20-
Inventory Turnover
3.853.395.184.544.50-
Quick Ratio
1.443.073.668.882.8017.79
Current Ratio
1.893.714.089.573.0518.25
Return on Equity (ROE)
-147.84%-125.42%-70.58%-74.75%-80.28%-
Return on Assets (ROA)
-26.52%-28.95%-29.40%-30.63%-31.16%-
Return on Capital (ROIC)
-29.41%-33.31%-33.00%-33.75%-35.29%-
Earnings Yield
-2027.43%-398.91%-136.82%-12.31%--
FCF Yield
-845.83%-306.32%-121.90%-12.18%--
Buyback Yield / Dilution
-2.24%-1.31%-61.69%-264.34%-0.03%-
Total Shareholder Return
-2.24%-1.31%-61.69%-264.34%-0.03%-
Source: S&P Capital IQ. Standard template. Financial Sources.